Differential effects of 20-epi vitamin D analogs on the vitamin D receptor homodimer

Journal of Bone and Mineral Research

Volumn 14, Issue 4, 1999, Pages 509-517

  Koszewski, Nicholas J ^a   Reinhardt, Timothy A ^b   Horst, Ronald L ^b  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

20 EPI 22 ETHOXY 24A,26A,27A TRIHOMO 9,10 SECOCHOLESTA 5,7,10(19) TRIEN 23 YNE 1ALPHA,3BETA,25 TRIOL; CALCITRIOL; LEXACALCITOL; RETINOID X RECEPTOR; SEOCALCITOL; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR;

AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONFORMATIONAL TRANSITION; DRUG RECEPTOR BINDING; ELECTROPHORETIC MOBILITY; HUMAN; IMMUNOBLOTTING; MOLECULAR INTERACTION; MOUSE; NONHUMAN; OSTEOPOROSIS; PROTEIN CONFORMATION; RECEPTOR AFFINITY;

EID: 0033030495     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1999.14.4.509     Document Type: Article

References (45)

1. 3 in the murine myelomonocytic leukemia cell line WEHI-3. Cancer Res 46:6316-6321.
2. 3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): Receptor-mediated maturation to macrophage-like cells. J Cell Biol 98:391-398.
3. Colston KW, Berger U, Coombes RC 1989 Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet 1:188-191.
4. 3 analogues in a cell density-, calcium-and serum-dependent manner. Pharmacol Toxicol 80:49-56.
5. Bouillon R, Okamura WH, Norman AW 1995 Structure-function relationships in the vitamin D endocrine system. Endocr Rev 16:200-257.
6. Norman AW 1995 The vitamin D endocrine system: Manipulation of structure-function relationships to provide opportunities for development of new cancer chemopreventive and immunosuppressive agents. J Cell Biochem 22 (Suppl):218-225.
7. Berg JP, Liane KM, Bjorhovde SB, Bjoro T, Torjesen PA, Haug E 1994 Vitamin D receptor binding and biological effects of cholecalciferol analogues in rat thyroid cells. J Steroid Biochem Mol Biol 50:145-150.
8. 3 response element. Leuk Res 19:147-158.
9. 3 analogues and their 20-epi homologues with the vitamin D receptor. J Biol Chem 272:3336-3345.
10. 3-analogs on osteoblast-like cells and on in vitro bone resorption. J Steroid Biochem Mol Biol 55:337-346.
11. 3 analogues: A novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines. Cancer Res 55:2822-2830.
12. 3 analogues: A novel class of potent regulators of cell growth and immune responses. Biochem Pharmacol 42:1569-1575.
13. Ryhanen S, Mahonen A, Jaaskelainen T, Maenpaa PH 1996 Synthetic 20-epi analogs of calcitriol are potent inducers of target gene activation in osteoblastic cells. Eur J Biochem 238:97-103.
14. 3 analog KH1060. Proc Natl Acad Sci USA 93:10685-10690.
15. 3 are associated with enhanced activation of the vitamin D receptor. J Biol Chem 270:10551-10558.
16. Vaisanen S, Juntunen K, Itkonen A, Vihko P, Maenpaa PH 1997 Conformational studies of human vitamin-D receptor by antipeptide antibodies, partial proteolytic digestion and ligand binding. Eur J Biochem 248:156-162.
17. Zhao XY, Eccleshall TR, Krishnan AV, Gross C, Feldman D 1997 Analysis of vitamin D analog-induced heterodimerization of vitamin D receptor with retinoid X receptor using the yeast two-hybrid system. Mol Endocrinol 11:366-378.
18. 3 analogue shows relation to promoter selectivity. J Cell Biochem 66:552-562.
19. Pakkala I, Savli H, Knuutila S, Binderup L, Pakkala S 1997 CB1093, a novel vitamin D analog: Effects on differentiation and clonal growth on HL-60 and de novo leukemia cells. Leuk Res 21:321-326.
20. Haq M, Kremer R, Goltzman D, Rabbani SA 1993 A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo. J Clin Invest 91:2416-2422.
21. 3 analog, EB1089, on hematopoietic stem cells from normal and myeloid leukemic blasts. Leukemia 10:1751-1757.
22. James SY, Mackay AG, Binderup L, Colston KW 1994 Effects of a new synthetic vitamin D analogue, EB1089, on the oestrogen-responsive growth of human breast cancer cells. J Endocrinol 141:555-563.
23. Colston KW, Mackay AG, James SY, Binderup L, Chander S, Coombes RC 1992 EB1089: A new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro. Biochem Pharmacol 44:2273-2280.
24. 3 and 9-cis-retinoic acid act synergistically to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G1. Endocrinology 138:1491-1497.
25. 3 analogs: Effect on leukemic clonal growth and differentiation, and on serum calcium levels. Leuk Res 19:65-72.
26. 3 analogues is not mediated by inhibition of the AP-1 pathway, but may be related to promoter selectivity. Oncogene 11:1853-1858.
27. 3 in human breast-cancer MCF-7 cells is related to promoter selectivity. Int J Cancer 67:739-742.
28. 3 (VD) analogues MC903, EB1089 and KH1060 activate the VD receptor: Homodimers show higher ligand sensitivity than heterodimers with retinoid X receptors. J Steroid Biochem Mol Biol 51:137-142.
29. Koszewski NJ, Reinhardt TA, Horst RL 1996 Vitamin D receptor interactions with the murine osteopontin response element. J Steroid Biochem Mol Biol 59:377-388.
30. Koszewski NJ, Reinhardt TA, Langub MC, Malluche HH, Horst RL 1998 Selectivity of a C-terminal peptide antiserum for different DNA-binding states of the vitamin D receptor. Arch Biochem Biophys 349:388-396.
31. 3 receptor in the absence of the retinoid X receptor. Mol Endocrinol 8:265-273.
32. 3 receptor (VDR) homodimers into VDR-retinoid X receptor heterodimers. Mol Cell Biol 14:3329-3338.
33. Nishikawa J, Kitaura M, Matsumoto M, Imagawa M, Nishihara T 1994 Difference and similarity of DNA sequence recognized by VDR homodimer and VDR/RXR heterodimer. Nucleic Acids Res 22:2902-2907.
34. Masuyama H, Brownfield CM, St-Arnaud R, MacDonald PN 1997 Evidence for ligand-dependent intramolecular folding of the AF-2 domain in vitamin D receptor-activated transcription and coactivator interaction. Mol Endocrinol 11:1507-1517.
35. 3 receptor identifying C-terminal amino acids required for transcriptional activation that are functionally dissociated from hormone binding, heterodimeric DNA binding, and interaction with basal transcription factor IIB, in vitro. J Biol Chem 272:14592-14599.
36. Nakajima S, Hsieh JC, MacDonald PN, Galligan MA, Haussler CA, Whitfield GK, Haussler MR 1994 The C-terminal region of the vitamin D receptor is essential to form a complex with a receptor auxiliary factor required for high affinity binding to the vitamin D-responsive element. Mol Endocrinol 8:159-172.
37. 3-dependent cell-free transcription. Mol Cell Biol 17:1923-1937.
38. Schulman IG, Li C, Schwabe JW, Evans RM 1997 The phantom ligand effect: Allosteric control of transcription by the retinoid X receptor. Genes Dev 11:299-308.
39. Jurutka PW, Hsieh JC, MacDonald PN, Terpening CM, Haussler CA, Haussler MR, Whitfield GK 1993 Phosphorylation of serine 208 in the human vitamin D receptor: The predominant amino acid phosphorylated by casein kinase II, in vitro, and identification as a significant phosphorylation site in intact cells. J Biol Chem 268:6791-6799.
40. 3 modulates phosphorylation of serine 205 in the human vitamin D receptor: Site-directed mutagenesis of this residue promotes alternative phosphorylation. Biochemistry 33:4300-4311.
41. Jurutka PW, Hsieh JC, Nakajima S, Haussler CA, Whitfield GK, Haussler MR 1996 Human vitamin D receptor phosphorylation by casein kinase II at Ser-208 potentiates transcriptional activation. Proc Natl Acad Sci USA 93:3519-3524.
42. 3 analogs EB1089 and KH1060. Endocrinoiogy 136:812-815.
43. Xie SP, James SY, Colston KW 1997 Vitamin D derivatives inhibit the mitogenic effects of IGF-I on MCF-7 human breast cancer cells. J Endocrinol 154:495-504.
44. 3 receptor homodimer [published erratum appears in J Cell Biochem 1996 Jul; 62 (1):142]. J Cell Biochem 60:322-333.
45. Xie Z, Bikle DD 1997 Cloning of the human phospholipase C-γ1 promoter and identification of a DR6-type vitamin D-responsive element. J Biol Chem 272:6573-6577.